The death of a Pasvalys vaccinated with COVID-19 upset the liars



[ad_1]

A user of the social network shared a series of points intended to discourage people from getting vaccinated with AstraZeneca about the death of a person vaccinated with COVID-19 last Friday, but the post is full of misleading information. Lie Detector provides explanations on what and why the statements made public on Facebook are incorrect.

AstraZeneca itself has admitted that it does not recommend vaccinating people over 55 with the vaccine they have developed. Why? Because no medical studies have been done in the elderly, they cannot say how the vaccine will work or what side effects it will have. ” [klaidinančios žinutės „Facebook“ citata]

In fact, vaccination of the AstraZeneca elderly was not recommended by the vaccine developers themselves, but rather by a committee of the German Agency for Disease Control, but the committee’s conclusions state that vaccination should not be administered to people over the age of 65 and not 55, according to misleading message.

This was not due to fears of side effects, but rather because, according to German health authorities, there was insufficient data on the effectiveness of this vaccine in people over 65 years of age.

For this reason, in Germany, the AstraZeneca vaccine is only recommended for people 18 to 64 years of age. In all other respects, the vaccine developed by AstraZeneca is recognized as inferior to other vaccines developed by Pfizer and BioNTech and Moderna approved for use in the European Union (EU).

The UK and the vaccine’s own developers, AstraZeneca and the University of Oxford, disagreed with Germany’s view on the use of the vaccine in the elderly, arguing that although fewer older people participated in the study, the results initials were promising and the level of protection. it was very high, similar in all age groups.

Thus, contrary to what the author of the post on the social network Facebook claims, the AstraZeneca vaccine was also tested in the elderly, only the latter not as much as in studies of vaccines from other manufacturers.

Of the more than 11 thousand. Only 660 people in the vaccine trials were over 65, but only two of those vaccinated in this group were diagnosed with COVID-19.

Following Germany’s lead in some countries and ordering AstraZeneca to vaccinate only the very young, the World Health Organization (WHO) has responded. At a press conference on February 10, the organization announced that WHO recommends that people over 65 get vaccinated with AstraZeneca.

The Expert Panel that advised the WHO based its decision on the fact that, although many older people have not participated in clinical trials of the vaccine, the available data suggests that the vaccine may help prevent complications from COVID-19. , hospitalization and death, which are particularly important factors in this age group.

“The IWT director is lying and it is demagoguery that there are no deaths from covid-19 vaccines in the world. Even the Lithuanian-language media reported on them. <...> The VAERS system records countless cases of various complications. ” [klaidinančios žinutės „Facebook“ citata]

It is not true that deaths caused by COVID-19 vaccines have been reported around the world. Sources attached by the author of the post report deaths after vaccination, not from it. Not 23 people of honorable age who have been vaccinated against the new coronavirus have died in Norway, nor is the event in California related to the effects of vaccines.

Many countries have systems for reporting adverse drug reactions, but any reports of serious adverse reactions or even death must be thoroughly investigated to understand whether the drug actually caused these effects. Research often reveals that the disease was caused by entirely different causes.

All COVID-19 vaccines approved for use in the EU, including Lithuania, are considered safe and effective. Their safety and the level of protection they provide against the virus have been tested in clinical trials involving tens of thousands of volunteers.

According to experts, any serious side effects or reports of death should be evaluated with extreme caution and without hasty conclusions.

The American portal ABC News was interviewed by the Boston Children’s Hospital epidemiologist dr. Mr Brownstein stressed the importance of taking into account the fact that older people with chronic diseases and other health problems are the first to be vaccinated worldwide, and that it is necessary to distinguish between certain adverse reactions due to vaccination and those immediately after vaccination. the vaccine had nothing to do with the disorder.

“There is no clear system in Lithuania on how to record complications and / or death from the vaccine.” [klaidinančios žinutės „Facebook“ citata]

Fake. In case of adverse reactions to a vaccine or other medicine in Lithuania, it is possible to report it to the State Medicines Control Agency by filling in this form.

“Why is there no question why South Africa is completely abandoning the AstraZeneca vaccine?” [klaidinančios žinutės „Facebook“ citata]

The representatives of the Republic of South Africa (PAR) themselves responded to this question by announcing the abandonment of the AstraZeneca vaccines. The country intended to vaccinate healthcare workers with the AstraZeneca vaccine, but the vaccine has been shown to be less effective against the viral mutation that dominates PAR, which accounts for about 90 percent of the vaccine. all new infections, so it was decided to abandon the purchased vaccine doses.

Instead, PAR healthcare workers are being vaccinated with a vaccine developed by Johnson & Johnson, which has been shown in studies to be more effective against the dominant mutation of the virus in Africa, reaching 57%. efficacy in avoiding moderate to severe symptoms of COVID-19 disease.

Based on this information, it can be said that the author of the message shared on the social network Facebook was incorrect.

It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source.



[ad_2]